Author:
Ahmad Narmeen,Karim Hersh,Rasool Luqman,Ali Khanzad,Mahmood Mohammed,Osman Tara,Hamakhan Chawan
Abstract
Backgroundβ-thalassemia is a most common hereditary disease where the patients suffer from decreased or absence of beta-globin chain synthesis, which leads to hemolytic anaemia and other complications. Very little data about beta-globin mutations in the Kurdish population is available to date.
ObjectiveThis study aimed to provide a more precise picture of the β-thalassemia mutations spectrum and to estimate their frequencies.
MethodsA cohort of 100 β-thalassemia patients was tested to detect mutations in the beta-globin gene’s regions (3 exons and two introns) using molecular techniques (polymerase chain reaction and Sanger sequencing).
ResultsIn this study, a total of 31 beta-thalassemia mutations were identified. The results showed that IVSII-666 C>T and IVSII-16 G>C were predominant over other mutations, with 59% of thalassemic patients having these mutations. Other common mutations found, in order of decreasing frequency, were Cd2 T>C, IVSII-74 T>G, IVS1-110 G>A, IVSI-5 G>C, IVSII-1 G>A, IVSII-81 C>T. The remaining mutations were uncommon and accounted for a few cases. More importantly, five novel beta-thalassemia mutations, namely, IVSII-13G>A, IVSII-14 A>C, IVSII-17 delC, IVSII-68_69 dupG, and Cd2/3 +C, were discovered which have not been previously reported in other populations.
ConclusionThe results obtained in this study can be used as a guide before prenatal diagnosis and during premarital screening of β-thalassemia in the Kurdish population.
Publisher
Journal of Zankoy Sulaimani - Part A
Reference30 articles.
1. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):1–15.
2. Boonyawat. B, Monsereenusorn. C, Traivaree. C. Molecular analysis of beta-globin gene mutations among Thai beta-thalassemia children : results from a single centre study. Appl Clin Genet. 2014;7:253–8.
3. Elizabeth G, Ann MTJA. Genotype-phenotype diversity of beta-thalassemia in Malaysia: Treatment options and emerging therapies. Med J Malaysia. 2010;65(4):256–60.
4. Sadiq MF, Eigel A, Horst J. Spectrum of β-thalassemia in Jordan: Identification of two novel mutations. Am J Hematol. 2001;68(1):16–22.
5. Xu L, Chen M, Huang H, Lin N, Chen L, Wang Y, et al. Identification of a novel pre-terminating mutation in human HBB gene as a cause of beta(0)-thalassemia phenotype. Int J Clin Exp Pathol. 2019;12(8):3070–6.